Ethosuximide Capsules and Insulin lispro Subcutaneous
Determining the interaction of Ethosuximide Capsules and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethosuximide
Brand name: Zarontin
Synonyms: Ethosuximide
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ethosuximide Capsules-Insulin NPH
- Ethosuximide Capsules-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Ethosuximide Capsules-Insulin NPH (Vials)
- Ethosuximide Capsules-Insulin NPH and Insulin Regular
- Ethosuximide Capsules-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Ethosuximide Capsules-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Ethosuximide Oral Solution
- Insulin lispro Subcutaneous-Ethosuximide Solution
- Insulin lispro Subcutaneous-Ethosuximide Syrup
- Insulin lispro Subcutaneous-Ethotoin
- Insulin lispro Subcutaneous-Ethynodiol diacetate and Ethinyl Estradiol
- Insulin lispro Subcutaneous-Ethyol